Thermo Fisher Scientific Inc. (TMO) — closed signal from October 21, 2025
Target reached Published before the outcome was known, scored automatically when the window closed on January 19, 2026.
Predicted vs. what happened
What happened
Hit or exceeded the predicted growth inside the window.
The thesis — published October 21, 2025
Thermo Fisher is a well-liked name in medical tools and services, and buyers have been active. A key growth area it serves, bioseparation, is expected to reach $45.1B by 2030, which supports steady demand. Buying near $550-$560 aims to join an ongoing uptrend while staying careful because mood can move faster than the numbers. We look for a steady 0-3 month climb, especially on days when trading is heavier than normal.
Primary drivers
- Bioseparation could reach $45.1B by 2030, supporting strong long-run demand
- Trend is firm and buying interest has been stronger than selling lately
- The stock stays popular with investors, reinforcing steady interest
- Near-term results are coming soon and may guide the next few months
How it played out
TMO: strong rise, target not reached
Lyra published TMO at $557.75 on 2025-10-21, looking for 14% growth over a short-term window. The thesis pointed to bioseparation demand, a firm trend, stronger buying interest than selling, steady investor interest, and near-term results that could guide the next few months.
Inside the window from 2025-10-21 to 2026-01-19, TMO rose but did not reach the $635.36 target. It peaked at $629.87 on 2026-01-15, a 12.9% gain. It ended at $618.72. The thesis mostly played out on direction and strength, but the target was missed.
What happened during the window
On October 29, 2025, Thermo Fisher announced a cash deal to buy Clario, with $8.9 billion upfront and up to $525 million in milestones. The deal was expected to close by mid-2026.
Prices are shown split- and dividend-adjusted, matching what public charts show today.
Share this receipt
A scored call, published before the outcome was known. Paste the link anywhere — it unfurls as the card above.
Read the next call before it closes.
This is one signal, scored after the fact. Today’s picks come with the same plain-language thesis — published before anyone knows the outcome.